Arbouw, ME, Movig, KL, Koopmann, M, Poels, PJ, Guchelaar, HJ, Egberts, TC, Neef, C, van Vugt, JP. Glycopyrrolate for sialorrhea in Parkinson disease: a randomized, double-blind, crossover trial. Neurology 2010; 74(15): 1203–1207.CrossRefGoogle Scholar

Man, WH, Colen-de Koning, JC, Schulte, PF, Cahn, W, van Haelst, IM, Doodeman, HJ, Egberts, TC, Heerdink, ER, Wilting, I. The effect of glycopyrrolate on nocturnal sialorrhea in patients using clozapine: a randomized, crossover, double-blind, placebo-controlled trial. J Clin Psychopharmacol 2017; 37(2): 155–161.CrossRefGoogle Scholar

Mestre, TA, Freitas, E, Basndwah, A, Lopez, MR, de Oliveira, LM, Al-Shorafat, DM, Zhang, T, Lui, JP, Grimes, D, Fox, SH. Glycopyrrolate improves disability from sialorrhea in Parkinson’s disease: a 12-week controlled trial. Mov Disord 2020; 35(12): 2319–2323.CrossRefGoogle ScholarPubMed

AHFS Drug information, 2012. Bethesda: American Society of Health-System Pharmacists. Accessed on 18 December 2022 via www.medicinescomplete.com.Google Scholar

Glycopyrronium. In: Brayfield, A (Ed.), Martindale: The Complete Drug Reference. London: The Royal Pharmaceutical Society of Great Britain. Accessed on 18 December 2022 via www.medicinescomplete.com.Google Scholar

Glycopyrronium. In: DRUGDEX® System (electronic version). Truven Health Analytics, Greenwood Village, Colorado, USA. Accessed on 18 December 2022 via www.micromedexsolutions.com.Google Scholar

Joint Formulary Committee. British National Formulary (online). London: BMJ Group and Pharmaceutical Press. Accessed on 18 December 2022 via www.medicinescomplete.com.Google Scholar

Lee, ZI, Yu, KJ, Lee, DH, Hong, SK, Woo, SB, Kim, JM, Park, D. The effect of nebulized glycopyrrolate on posterior drooling in patients with brain injury: two cases of different brain lesions. Am J Phys Med Rehabil 2017; 96(8): e155–e158.CrossRefGoogle ScholarPubMed

Plunkett, C. Sialorrhoea treated with inhaled glycopyrronium. BMJ Support Palliat Care 2021; 11(4): 406–407.CrossRefGoogle ScholarPubMed

Summary of product characteristics – glycopyrronium bromide 1 mg tablets. Dawa Ltd. Electronic Medicines Compendium: glycopyrronium bromide 1 mg tablets – summary of product characteristics (SmPC) – (emc). Accessed on 18 December 2022 via www.medicines.org.uk.Google Scholar